Objective The purpose of this study is to investigate the incidence of determinants for
virologic failure and to identify predisposing factors to enhance treatment efficacy. Tackling …

There have been limited studies linking baseline factors, including the viral load (VL) test,
with virological non-suppression since the introduction of dolutegravir (DTG)-based …

Background Children living with human immunodeficiency virus (HIV, CLWH) are at high
risk of tuberculosis (TB) and face poor outcomes, despite antiretroviral therapy (ART). We …

Background Although safe and effective anti-retrovirals (ARVs) are readily available, non-
adherence to ARVs is highly prevalent among people living with human immunodeficiency …

Background High viral load during pregnancy and breastfeeding period is the risk factor for
vertical transmission of human immunodeficiency virus (HIV). Currently, Dolutegravir (DTG) …

Introduction Despite the need for reliable questionnaires to monitor self-management in
chronic disease patients, such tools are lacking in developing countries. This study aims to …

The complete and prolonged suppression of viral load is the primary objective of HAART in
people living with HIV. Some people may experience therapeutic failure, while others may …

(1) Background: HIV drug resistance (HIVDR) poses a significant challenge to the
effectiveness of antiretroviral therapy and the overall management of HIVand AIDS …

Background Limited epidemiologic studies have been conducted in Jordan describing the
HIV epidemic. This study aimed to address this gap to inform HIV prevention and control …

Background Antiretroviral therapy (ART) is one of the most effective ways for HIV-infected to
treat AIDS. However, it is difficult to start ART among young people those newly diagnosed …